Atypical Parkinsonism Blog & News

PMPRB: Friend or Foe of Rare Disease Drug Strategy In February 2019 the federal government committed $1billion over two years starting in 2022 ...

AWARENESS APPAREL & More Show your Support and Help Raise Awareness for PSP and Atypical Parkinsonism! FREE Shipping! No TAX! 5% of all sales ...

US FDA Allows Trial to Proceed for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP).LOS ALTOS, CALIF, April 25, 2020– Ret...

Association of Stress-Related Disorders With Subsequent Neurodegenerative Diseases By: Huan Song, MD, PhD; Johanna Sieurin, MSc; Karin Wirdefeldt, ...

RETROTOPE UPDATE! I will be meeting with the RETROTOPE team tomorrow March 5th in California and will provide an update shortly after. In the inter...

From Sarah at Retrotope regarding RT001 Clinical Trials for PSP! Do not lose hope. Retrotope is in the process of developing drugs to treat a varie...

Written by Matthew J. Barrett, an associate professor of neurology and a movement disorder specialist at Virginia Commonwealth University in Richmo...

US FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP). LOS ALTOS, CALIF, February 18...

By: Laura Louizos The diagnosis is only a clinical diagnosis. The only way to officially confirm PSP, MSA or CBD is an autopsy. (This is why Brain ...

Canadian Hospice Palliative Care Association Releases New Resources to Support the Legal Processes of Advance Care Planning (ACP) in Canada I...

Has you or your loved one been misdiagnosed or undiagnosed and you are searching for answers? Has PSP, MSA or CBD been mentioned? It might be helpf...

Parkinson's Canada has launched a great resource and program to help healthcare providers and care facilities understand the importance of patients...